Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for multifocal motor neuropathy in Chinese patients
ChiCTR2500107628Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of immune globulin in multifocal motor neuropathy (MMN), sponsored by Peking Union Medical College Hospital. Primary endpoints: MMN-RODS score change, MRC-14 total score change and 1 more. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
immune globulin
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on ChiCTR2500107628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107628.